ESCRS - Supplement: GLAUKOS Istent Inject W Supplement 2022 ;
ESCRS - Supplement: GLAUKOS Istent Inject W Supplement 2022 ;
Supplements

Supplement: GLAUKOS Istent Inject W Supplement 2022

Supplement: GLAUKOS Istent Inject W Supplement 2022

Affecting an estimated 76 million people worldwide in 2020 (1), glaucoma is the leading cause of irreversible vision loss and the second leading cause of blindness worldwide (2). Open angle glau-coma (OAG) is the most common form, occurring in 74% of diagnosed glaucoma cases (3, 4). It is often seen in conjunction with cataract, with approximately one-in-five cataract patients also needing glaucoma medication (5). These numbers present both a daunting challenge and a major opportunity. Elevated intraocular pressure (IOP) remains the major risk factor for glaucoma, and most current treatments, including pharmacological, laser and surgical interventions, focus on lowering IOP (6). Yet each have drawbacks. Ocular hypotensive medications are reasonably safe and effective, but their pressure-reducing effects may wane over time, they can lead to ocular surface disease and conjunctival hyperemia, and adherence is notoriously problematic (7-11). Laser trabeculoplasty reliably reduces IOP but can lose effectiveness after three to five years (38-40) and some forms may induce inflammation in the intermediate term (12). And while incisional surgeries such as trabeculectomy and tube shunt implantation can reduce IOP dra-matically, they expose patients to safety risks, including endophthalmitis and hypotony, that can persist for the lifespan of treatment (13-15).

Tags: glaucoma
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Read more...

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

Read more...

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Read more...

Piecing Together a Solution

What is the best use of robotics and AI in cataract and refractive surgery?

Read more...

Advances in Toric IOL Alignment

Biomorphometric approaches offer high precision and increase efficiency.

Read more...

Library of Short Videos Complements Educational Offerings

Read more...

Tackling Waste in Retinal Surgery

Reducing waste from intravitreal injections is an achievable goal.

Read more...

The Modern Era of Refractive Surgery

New technologies for screening and treatment qualify more patients for intervention.

Read more...

Monofocal Plus Finding the Balance

Enhanced monofocals may be the future standard of care in cataract patients.

Read more...

Growing Options Optimise Outcomes in Cataract Surgery

Understanding the promise and potential problems of AI-based IOL formulas.

Read more...

;